Collaborative Projects

BEACONS Newborn Genome Screening Study Selects Seven Sites, Finalizes Gene List

GenomeWeb |

January 2026

Press Release

GenomeWeb celebrates the BEACONS team’s announcement regarding the selection of 7 U.S. states and territories selected to assess the feasibility of integrating whole genome sequencing into public health newborn screening. The team also published the curated gene list, which consists of 746 genes associated with 777 genetic conditions, all clinically actionable within the first year … Continued

BEACONS Selects Seven Sites, Finalizes Gene List for Genomic Newborn Screening Study

Ariadne Labs Press |

January 2026

Press Release

Ariadne Labs covers the announcement of two major milestones from the newly NIH-funded study, BEACONS. Six states and one U.S. territory have been selected to assess feasibility of integrating whole genome sequencing into public health newborn screening. The BEACONS team has also published the curated gene list, consisting of 777 genetic conditions, all actionable within … Continued

Study: Major Gaps Block Genetics Evaluation and Testing for Black and Low Income Patients

Newswise of Perelman School of Medicine at the University of Pennsylvania |

December 2025

Press Release

This press release describes crucial findings from a joint study by the Perelman School of Medicine at the University of Pennsylvania and Massachusetts General Hospital. The research team highlights systemic obstacles in primary care, lack of referral guidelines, and workforce shortages, and they call for interventions like decision-support flags in electronic health records, embedded genetic … Continued

Dr. Robert Green Speaks at TED on Bringing Preventive Genomics into Everyday Care

Ariadne Labs News |

September 2025

Press Release

Ariadne Labs celebrates Dr. Robert Green’s TED Talk, which explores how preventive genomics could transform medicine by identifying disease risk before symptoms ever appear, even from birth. Drawing on the world’s first DNA screening of healthy newborns, he makes the case for a future of care focused on prediction and prevention, not just treatment.

The Double-Edged Code: The promise and peril of personal genomics

Inside Precision Medicine |

December 2025

Press

This article explores the critical transition toward genomic implementation into precision health, examining the economic, clinical, and ethical frameworks required to integrate genomic data into everyday care. Featuring insights from G2P Director Dr. Robert Green and other leading experts, it challenges us to consider how we will responsibly navigate the most intimate information we possess.

APHL Convenes Newborn Whole Genome Sequencing Initiative, Ensuring Public Health Laboratory Input

APHL Blog |

December 2025

Press

APHL celebrates the launch of BEACONS, the nation’s first multi-state initiative evaluating whether whole genome sequencing (WGS) can be responsibly integrated into the U.S. newborn screening system. With a $14.4M NIH award and invaluable participation from public health labs across the country, BEACONS will test how WGS affects workflows, consent, data systems, and the actionable … Continued

Operationalizing the Wilson-Jungner principles for the genomics era: Consensus recommendations from the International Consortium on Newborn Sequencing

Downie L Yeo J Minten T Heald R Ansel D Baker M Balciuniene J Berg JS Boemer F Chung WK Cope HL Eckstein DJ Encina N Faivre L Ferlini A García-Villoria J Gelb MH Aledo-Castillo JMG Golden-Grant K Parad RB Shah N Stark Z Sund KL Tsipouras P To M Bick D Green RC ICONS Gold NB

Genetics in Medicine October 2025

NIH Funds Multi-State Pilot For Genome Sequencing in Newborn Screening

News Medical Net |

October 2025

Press, Press Release

Dr. Green describes the impact of the novel, NIH-funded BEACONS study: “For more than 50 years, newborn screening has been a beacon of trust, saving children’s lives by analyzing a few drops of blood after birth. BEACONS brings the next generation of hope, giving families the option of genomic screening for hundreds of additional conditions … Continued

First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

MGB Newsroom |

October 2025

Press, Press Release

Funded by a $14.4 million award from the National Institutes of Health (NIH) Common Fund Venture Program, BEACONS will pilot the integration of whole genome sequencing into existing state newborn screening systems. The study will recruit, consent, and enroll up to 30,000 newborns in as many as 10 states over the next three years, a … Continued

Critical bottlenecks in rare disease research and care: A community perspective

McMurry J, Sizer A, Allaway R, Boerkoel C, Chen AJ, Colquitt J, Cummings J, Dutta A, Fitter N, Green RC, Hanson A, Harker E, Harris N, Hovinga C, Kahn A, Keil H, Kessler R, Lange L, Loaiza-Bonilla A, Luchkina N, Luellen E, Movaghar A, Pastinen T, Rountree E, Rudrapatna V, Sand A, Schmolly K, Short P, Sirota M, Siwo G, Tatonetti N, Vidra N, Vij F, Volchenboum S, Walden A, Walls RL, Washington P, Wenzlau D, Wenzlau M, Wheeler M, Son Rigby C, Haendel M

Zenodo February 2025

Data Sharing: A consortium-sanctioned activity to support global research and discovery

International Consortium on Newborn Sequencing |

October 2023

Video

At the 2023 International Conference on Newborn Sequencing (ICoNS), Dr. David Bick; Dr. Nidhi Shah, G2P collaborator; and Rose Heald, G2P team member, share plans to share and harmonize data amongst newborn sequencing projects internationally.

Awareness and utilization of genetic testing among Hispanic and Latino adults living in the US: The Hispanic Community Health Study/Study of Latinos

Christensen KD, Zhang M, Galbraith LN, Granot-Hershkovitz E, Nelson SC, Gonzalez S, Argos M, Perreira KM, Daviglus ML, Isasi CR, Cai J, Talavera GA, Blout Zawatsky CL, Green RC, Isasi R, Kaplan R, Sofer T

Human Genetics and Genomics Advances January 2023

Precision Population Health

November 2022

Precision Population Health (PPH) aims to bring the power of precision medicine to primary care settings, where it can be used to treat disease or prevent it before it occurs. The initiative combines expertise from Ariadne Labs and Genomes2People, creating a world-class collaboration of clinical genomics experts and implementation scientists to overcome the challenges that … Continued

Combining science and service as a VA genetic counselor

VAntage Point |

March 2021

Press

“In 2019, [G2V’s] Morgan Danowski graduated and joined Boston VA. There, she supports VA’s Million Veteran Program (MVP), now the world’s largest genomics research program. The program takes DNA from participating Veterans and information on their health, lifestyle and military experiences and exposures to better understand disease in Veteran populations. With over 830,000 Veterans enrolled, … Continued

Sanford Imagenetics METRICS

July 2020

Genetic testing has the potential to revolutionize primary care by helping health care providers tailor medication choices to their patients’ genetic information and by identifying inherited risk factors for disease before patients develop symptoms. Few health systems have integrated genetic testing into general patient care to date and even fewer have developed the infrastructure to … Continued

Genomics and Life Insurance Working Group

November 2018

We have assembled a Genomics & Life Insurance Working Group of experts to explore themes, challenges and benefits of educating life insurers about genetic and genomics concepts. We would like to help them better understand how genetic and genomic testing can ultimately prolong individuals’ lives, resulting in a net benefit for patients and their life … Continued

Genomes2Veterans (G2V) Research Program

June 2018

Join Us ABOUT US At G2V, we envision a future where health care uses genomics to improve human health equitably. We work towards this vision in the following ways: We conduct biomedical research to determine the role of genetic and genomic technologies in improving the care and health outcomes of Veterans and other patients. Our … Continued

Econogenomics Working Group

October 2006

Genomic medicine has the potential to revolutionize patient care. Yet, major questions remain about the value it provides and its impact overall health care expenditures. Advocates hope that genomic medicine will help control expenditures by streamlining diagnostic processes, informing selection and dosing of treatments, and identifying at‐risk individuals to facilitate targeted prevention. The price of … Continued

Latest News From Genomes2People